1 January 2025 false Taxfiler 2024.6 07014242business:PrivateLimitedCompanyLtd2025-01-012025-12-31 070142422024-12-31 070142422025-01-012025-12-31 07014242business:AuditExemptWithAccountantsReport2025-01-012025-12-31 07014242business:FilletedAccounts2025-01-012025-12-31 070142422025-12-31 07014242business:Director12025-01-012025-12-31 07014242business:RegisteredOffice2025-01-012025-12-31 070142422024-12-31 07014242core:WithinOneYear2025-12-31 07014242core:WithinOneYear2024-12-31 07014242core:ShareCapitalcore:PreviouslyStatedAmount2025-12-31 07014242core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 07014242core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-12-31 07014242core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 07014242core:PreviouslyStatedAmount2025-12-31 07014242core:PreviouslyStatedAmount2024-12-31 07014242business:SmallEntities2025-01-012025-12-31 07014242countries:EnglandWales2025-01-012025-12-31 07014242core:FurnitureFittings2025-01-012025-12-31 07014242core:ComputerEquipment2025-01-012025-12-31 07014242core:FurnitureFittings2024-12-31 07014242core:ComputerEquipment2024-12-31 07014242core:FurnitureFittings2025-12-31 07014242core:ComputerEquipment2025-12-31 07014242core:RevaluationsIncreaseDecreaseInInvestments2025-12-31 07014242business:OrdinaryShareClass12025-01-012025-12-31 07014242business:OrdinaryShareClass12024-01-012024-12-31 07014242business:Director112025-01-012025-12-31 07014242business:Director112024-12-31 07014242business:Director112025-12-31 070142422024-01-012024-12-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 07014242 (England and Wales)
Al-Singary Medical Ltd Unaudited accounts for the year ended 31 December 2025
Al-Singary Medical Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Al-Singary Medical Ltd Company Information for the year ended 31 December 2025
Director
Mr Waleed Al-Singary
Company Number
07014242 (England and Wales)
Registered Office
44 LAVINGTON ROAD WORTHING BN14 7SN ENGLAND
Accountants
Maxwell-Gumbleton & Co. 1 West Street Lewes East Sussex BN7 2NZ
- 3 -
Al-Singary Medical Ltd Statement of financial position as at 31 December 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
4
669 
1,109 
Investments
5
72,109 
65,131 
72,778 
66,240 
Current assets
Debtors
6
1,067,544 
1,013,390 
Cash at bank and in hand
658,291 
619,701 
1,725,835 
1,633,091 
Creditors: amounts falling due within one year
7
(47,347)
(32,912)
Net current assets
1,678,488 
1,600,179 
Net assets
1,751,266 
1,666,419 
Capital and reserves
Called up share capital
8
1 
1 
Profit and loss account
1,751,265 
1,666,418 
Shareholders' funds
1,751,266 
1,666,419 
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 17 August 2026 and were signed on its behalf by
Mr Waleed Al-Singary Director Company Registration No. 07014242
- 4 -
Al-Singary Medical Ltd Notes to the Accounts for the year ended 31 December 2025
1
Statutory information
Al-Singary Medical Ltd is a private company, limited by shares, registered in England and Wales, registration number 07014242. The registered office is 44 LAVINGTON ROAD, WORTHING, BN14 7SN, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
20% straight line basis
Computer equipment
3 year straight line
Investments
Investments in shares are included at fair value.
Pension costs
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
- 5 -
Al-Singary Medical Ltd Notes to the Accounts for the year ended 31 December 2025
4
Tangible fixed assets
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 January 2025
3,412 
1,041 
4,453 
At 31 December 2025
3,412 
1,041 
4,453 
Depreciation
At 1 January 2025
2,303 
1,041 
3,344 
Charge for the year
440 
- 
440 
At 31 December 2025
2,743 
1,041 
3,784 
Net book value
At 31 December 2025
669 
- 
669 
At 31 December 2024
1,109 
- 
1,109 
5
Investments
Subsidiary undertakings 
Other investments 
Total 
£ 
£ 
£ 
Valuation at 1 January 2025
1,000 
64,131 
65,131 
Fair value adjustments
- 
6,978 
6,978 
Valuation at 31 December 2025
1,000 
71,109 
72,109 
6
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
Trade debtors
12,412 
11,116 
Amounts due from group undertakings etc.
1,000,814 
1,000,814 
Accrued income and prepayments
358 
- 
Other debtors
53,960 
1,460 
1,067,544 
1,013,390 
7
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Trade creditors
333 
454 
Taxes and social security
31,049 
24,310 
Other creditors
2,004 
1,959 
Loans from directors
12,431 
4,659 
Accruals
1,530 
1,530 
47,347 
32,912 
8
Share capital
2025 
2024 
£ 
£ 
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1 
1 
- 6 -
Al-Singary Medical Ltd Notes to the Accounts for the year ended 31 December 2025
9
Loans to directors
Brought Forward 
Advance/ credit 
Repaid 
Carried Forward 
£ 
£ 
£ 
£ 
Mr Waleed Al-Singary
Loan repayable on demand. Interest charged at the beneficial loan interest rate
- 
52,500 
- 
52,500 
- 
52,500 
- 
52,500 
Loan was advanced on the 16 December 2025.
10
Average number of employees
During the year the average number of employees was 2 (2024: 2).
- 7 -